523
Participants
Start Date
May 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Amiodarone
"Amiodarone Initial Dose~* Oral: 400 mg po TID for 3 days is recommended~* For patients incapable of taking oral: 150 mg IV bolus over 10 min, then 1 mg/min over 6 hours followed by 0.5 mg/min over 18 hours Maintenance Dose~* Oral: at least 200 mg/day to be continued until 60 days after randomization~* If drug cannot be given orally or via NG tube: 0.5 mg/min administered through central line (e.g., PICC) until oral dosing is started"
DC-cardioversion
DC-Cardioversion - frequency and duration determined by medical professional as medically needed
Rate Control
Beta-blocker and/or Calcium channel blockers and/or Digoxin - Dose, frequency and duration determined by medical professional as medically needed
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Montefiore Einstein Heart Center, The Bronx
University of Pennsylvania, Philadelphia
NIH Heart Center at Suburban Hospital, Bethesda
University of Maryland, Baltimore
University of Virginia Health Systems, Charlottesville
Duke University, Durham
Mission Hospital, Asheville
Emory University, Atlanta
The Ohio State University Medical Center, Columbus
Cleveland Clinic Foundation, Cleveland
University of Michigan Health Services, Ann Arbor
University of Wisconsin, Madison
Baylor Research Institute, Plano
Baylor College of Medicine, Houston
University of Southern California, Los Angeles
University of Alberta Hospital, Edmonton
Toronto General Hospital, Toronto
Montreal Heart Institute, Montreal
Centre Hospitalier de l'Université de Montréal, Montreal
Hôpital du Sacré-Cœur de Montréal, Montreal
Institut Universitaire de Cardiologie de Quebec (Hopital Laval), Québec
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Icahn School of Medicine at Mount Sinai
OTHER